Florey Institute of Neuroscience and Mental Health

Eight Aussie startups that raised $108.6 million this week

Roundup of eight funding deals: Synchron's Series D, plus raises by Lumonus AI, Hullbot, Nbryo, Cytophenix, Giftbee, Understanding Zoe and Zeligate, spanning medtech, robotics, agtech and AI.

Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily

Victoria slings $10 million at a NVIDIA AI supercomputer tackling medical research

The Victorian government has granted ACAMI at La Trobe University $10 million to help deploy NVIDIA DGX H200 supercomputers for AI-driven medical research, including a Florey collaboration on a childhood neurodegenerative disease.

Brandon BioCatalyst’s CUREator Incubator Boosts Preclinical and Health Security Biotech Innovations with $1.865m in funding.

Brandon BioCatalyst's CUREator incubator has granted an extra $1.865m across four Australian biotechs working on antibiotic prescribing, schizophrenia, muscular dystrophy and autoimmune therapies, on top of their initial awards.

Startup Daily TV: Melbourne biotech Tessara Therapeutics has developed a 'mini human brain' to help find better drugs to treat diseases such as Alzheimers

Startup Daily TV interviews Tessara Therapeutics' CEO about RealBrain, its 3D brain-tissue models for neurological drug discovery, and a fresh push to raise funds; the Melbourne biotech is also among the latest Tech23 companies.

Brandon Capital Partners launches new Medical Research Commercialisation Fund, seeks NZ institutional

Brandon Capital's Medical Research Commercialisation Fund has launched its fifth vehicle, MRCF5, completing a NZ$224 million first close and targeting NZ$267 million, while recalling earlier portfolio exits of Elastagen, Spinifex and Fibrotech.

Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Startup Daily